BIOT
Mastering GMP Manufacturing of Gene Therapy Nanoparticles
📝 Navigating GMP Manufacturing of mRNA-Lipid Nanoparticles explores challenges, technologies, and regulations in gene therapy production. 🔬💡🌍
Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines
🔬 GSK teams up with Elegen Bio to develop DNA-based medicines and vaccines, revolutionizing the field of biotechnology. 💉💊
Patient Advocate Slams FDA’s CAR-T Warning Labels: Is Patient Safety at Risk?
🔺 Patient advocate slams FDA decision on CAR-T warning labels, arguing it undermines patient knowledge and autonomy. 🔺 Warning labels may deter patients from seeking life-saving CAR-T therapies. 🔺 Advocates prioritize informed consent and patient education over warnings. 🔺 Critics fear labels could cause unnecessary fear and anxiety. 🔺 FDA decision raises concerns on patient safety vs. access to innovative therapies.
World’s First CRISPR Cell Therapy Approved for Sickle Cell – Solvias to Perform Testing
📰 Solvias will perform release testing on CASGEVY, the world's first CRISPRCas9 genome-edited cell therapy. 🧪💊🔬✅🌍
Dutch Biotech Firm Raises €75m to Fight Diseases
💰 Dutch biotech firm Forbion leads €75m funding for Calluna Pharma, a newly formed company targeting inflammatory and fibrotic diseases.
Catalent’s Game-Changing CAR-T Platform Revolutionizes Immunocellular Therapy
🚀 Catalent launches a plug-and-play CAR-T platform 🛠️ designed to streamline development and manufacturing of immunocellular therapies. 🌟🔬💼
Revolutionary Tech Boosts Quality & Efficiency in AAV Manufacturing
An Essential PAT Technology for Downstream Processing in AAV Manufacturing explores how PAT enhances AAV production quality and efficiency. 📰🔍🔬⚙️🌐
Roche Abandons AC Immune Collaboration Returns Drugs
📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅
EU Decision on Genomic Techniques: Last Chance Before Elections
📅 On January 22, 2024, EU Parliament calls for patent ban on NGT-1 breeds. Tomorrow, ENVI Committee gives input on draft law. Germany, Belgium, & Bulgaria abstain. Poland supports product labeling. Decision crucial before elections & new European Commission.
Gilead Ditches Oceanside Boosts Biologics in Foster City!
🚫 Gilead cancels Oceanside expansion plans 🌊, shifts biologics production to Foster City 🏙️. Read more about the move! 💥
